Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
The DOI matches its Crossref record; 134 of the 135 references it cites were found in a registry or an index.
Abstract
The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders. Small intermediates - soluble oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers. These emerging concepts are exemplified by Alzheimer's disease, in which amyloid beta-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation suggests that oligodendrocytes could potentially generate a relatively higher proportion of longer Aβ species, which are more prone to aggregation [28]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“and, consequently, could be more pathogenic than shorter Aβ species”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [28]
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [8]
In the citing paper
“Dysregulation of A peptide metabolism is hypothesized to initiate pathogenic cascades that lead to Alzheimer's disease (AD) (Haass and Selkoe, 2007).”
From microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain (2015) · cites this paper as Haass and Selkoe, 2007
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Self-citationSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“These and other findings led to the formal proposal of a hypothesis of disease in which excessive Aβ accumulation and deposition could trigger a complex downstream cascade that resulted in the symptoms of A”
ResultRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In a similar manner, breakthrough discoveries of causative genes allowed the subsequent identification of aggregation-prone proteins in disorders such as amyotrophic lateral sclerosis (ALS”
ResultUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“More recently, TDP43 was found to be deposited in tau- and synuclein-negative inclusions in a disorder designated as frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) as well as in AL”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Shortly thereafter, a distinct APP missense mutation was found in a family with early-onset A”
Background
Cited by
Items 801–900 of 1,119
Bridging the gap: From protein misfolding to protein misfolding diseases
Luheshi, L. M., & Dobson, C. M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.030 · Cited by 111
“eases, it is the precursors to amyloid formation, so called prefibrillar aggregates or oligomers that are likely to be primarily responsible for cellular damage in many cases [26].”
BackgroundTransient dynamics of Aβ contribute to toxicity in Alzheimer’s disease
Hubin, E., van Nuland, N. A. J., Broersen, K., & Pauwels, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1634-z · Cited by 104
“Soluble oligomers have commonly been associated with disease severity, the loss of synapses and neuronal damage (reviewed in [18]).”
BackgroundReese, L. C., Laezza, F., Woltjer, R., & Taglialatela, G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07447.x · Cited by 101
Fukumori, A., Fluhrer, R., Steiner, H., & Haass, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1443-10.2010 · Cited by 101
“-Secretase catalyzes the second and final processing step of the -amyloid precursor protein (APP), releasing the neurotoxic amyloid -peptide (A ), which is implicated in Alzheimer’s disease (AD) pathogenesis (Haass and Selkoe, 2007).”
BackgroundSelf-citationHammarström, P., Simon, R. A., Nyström, S., Konradsson, P., Åslund, A., & Nilsson, K. P. R. (2010) · Biochemistry · doi:10.1021/bi100922r · Cited by 105
Movsesyan, N., Ghochikyan, A., Mkrtichyan, M., Petrushina, I., Davtyan, H., Olkhanud, P. B., Head, E., Biragyn, A., Cribbs, D. H., & Agadjanyan, M. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002124 · Cited by 101
“The beneficial effects of anti-Ab antibody in reducing the soluble Ab forms have been emphasized, because Ab oligomers appear to play a critical role in the pathogenesis of AD [2].”
BackgroundInfluentialAlzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
Klyubin, I., Cullen, W. K., Hu, N.-W., & Rowan, M. J. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-25 · Cited by 100
“Several lines of evidence suggest that small highly diffusible Aβ aggregates may be responsible for memory impairment in AD [2,62].”
BackgroundSelf-Templated Nucleation in Peptide and Protein Aggregation
Auer, S., Dobson, C. M., Vendruscolo, M., & Maritan, A. (2008) · Physical Review Letters · doi:10.1103/physrevlett.101.258101 · Cited by 107
Faucher, P., Mons, N., Micheau, J., Louis, C., & Beracochea, D. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00245 · Cited by 100
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-121990 · Cited by 100
“A 42 aggregates much faster and may be directly related to the pathogenesis of AD [44].”
Freer, R., Sormanni, P., Vecchi, G., Ciryam, P., Dobson, C. M., & Vendruscolo, M. (2016) · Science Advances · doi:10.1126/sciadv.1600947 · Cited by 100
Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review
Khanam, H., Ali, A., Asif, M., & Shamsuzzaman (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.006 · Cited by 108
Moon, M., Jung, E. S., Jeon, S. G., Cha, M.-Y., Jang, Y., Kim, W., Lopes, C., Mook‐Jung, I., & Kim, K. (2018) · Aging Cell · doi:10.1111/acel.12866 · Cited by 108
Mori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004280 · Cited by 106
Ren, P., Chen, J., Li, B., Zhang, M., Yang, B., Guo, X., Chen, Z., Cheng, H., Wang, P., Wang, S.-B., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3050971 · Cited by 108
Oh, S. J., Lee, H., Jeong, Y. J., Nam, K. R., Kang, K. J., Han, S. J., Lee, K. C., Lee, Y. J., & Choi, J. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-72755-4 · Cited by 106
Frozza, R. L., Horn, A. P., Hoppe, J. B., Simão, F., Gerhardt, D., Comiran, R. A., & Salbego, C. G. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9776-8 · Cited by 123
“viewed as one of the most enigmatic and intractable problems in biomedicine [1].”
Nanomedicine for the Treatment of Alzheimer’s Disease
Gregori, M., Masserini, M., & Mancini, S. (2015) · Nanomedicine · doi:10.2217/nnm.14.206 · Cited by 99
Tarozzi, A., Morroni, F., Merlicco, A., Bolondi, C., Teti, G., Falconi, M., Cantelli‐Forti, G., & Hrelia, P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.006 · Cited by 107
“Sevral studies suggests that the A oligomers diffuse readily through he brain parenchyma and cause a selective synaptic dysfunction nd/or neuronal loss in cortex and hippocampus, two stricken brain egions in AD [7].”
BackgroundPicone, P., Carrotta, R., Montana, G., Nobile, M. R., Biagio, P. L. S., & Carlo, M. D. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.11.056 · Cited by 102
Panza, F., Solfrizzi, V., Imbimbo, B. P., Tortelli, R., Santamato, A., & Logroscino, G. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.883921 · Cited by 99
Liu, D.-S., Pan, X.-D., Zhang, J., Shen, H., Collins, N. C., Cole, A. M., Koster, K. P., Ben Aissa, M., Dai, X.-M., Zhou, M., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0002-2 · Cited by 99
“of this complex [114-116].”
α-Helix Mimetics as Modulators of Aβ Self-Assembly
Kumar, S., & Hamilton, A. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09734 · Cited by 99
Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity
Rajasekhar, K., Samanta, S., Bagoband, V., Murugan, N. A., & Govindaraju, T. (2020) · iScience · doi:10.1016/j.isci.2020.101005 · Cited by 99
“The oligomeric forms of Ab are considered to be highly lethal as they purge holes into the neuronal cell membrane and interact with synaptic cleft causing influx of excessive calcium into the cell disrupting the signaling pathways (Haass and Selkoe, 2007; Lee et al., 2017).”
BackgroundRational design of a conformation-specific antibody for the quantification of Aβ oligomers
Aprile, F. A., Sormanni, P., Podpolny, M., Chhangur, S., Needham, L.-M., Ruggeri, F. S., Perni, M., Limbocker, R., Heller, G. T., Sneideris, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919464117 · Cited by 98
“In particular, these oligomers have been shown to trigger various toxic pathways, including synaptic dysregulation, membrane permeabilization, oxidative stress, mitochondrial dysfunction, and activation of proinflammatory response (9, 11).”
Dinamarca, M. C., Ríos, J. A., & Inestrosa, N. C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00464 · Cited by 99
“Growing evidence from numerous laboratories suggest that soluble Aβ oligomers, more than monomers or fibrils, are responsible for Aβ cytotoxicity (Haass and Selkoe, 2007; Li et al., 2011).”
BackgroundInfluentialBaglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100066 · Cited by 98
González, J. F., Alcántara, A. R., Doadrio, A. L., & Sánchez-Montero, J. M. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1623201 · Cited by 98
“peptide (Aβ) which eventuates with β-amyloid senile plaques [5,6].”
BackgroundAfantitis, A., Melagraki, G., Koutentis, P. A., Sarimveis, H., & Kollias, G. A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.029 · Cited by 98
Kaniyappan, S., Chandupatla, R. R., Mandelkow, E., & Mandelkow, E. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.002 · Cited by 98
“Several groups have studied the toxic properties of tau aggregates, especially PHFs, but more recent evidence suggests that soluble or prefibrillar forms of aggregates are responsible for toxicity and cell death rather than the higher aggregates or PHFs [49].”
BackgroundYang, R., Zheng, Y., Wang, Q., & Zhao, L. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2759-z · Cited by 106
Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly
Abelein, A. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00370 · Cited by 109
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
Henley, D. B., Sundell, K. L., Sethuraman, G., Dowsett, S. A., & May, P. C. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.939167 · Cited by 98
Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease
Gong, Y., Lippa, C. F., Zhu, J., Lin, Q., & Rosso, A. L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.056 · Cited by 98
“The pathological lesion of AD includes three hallmark changes: amyloid plaques, neurofibrillary tangles and synaptic loss (Haass and Selkoe, 2007).”
BackgroundMosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97
“According to the amyloid cascade hypothesis [25], mitochondrial dysfunction arises downstream of A (cid:1) pathology, either in fibrillar or oligomeric form [26].”
Jacobsen, H., Ozmen, L., Caruso, A., Narquizian, R., Hilpert, H., Jacobsen, B., Terwel, D., Tanghe, A., & Bohrmann, B. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1405-14.2014 · Cited by 97
“There are several potential reservoirs of A independent from plaques, such as small, soluble aggregates (Haass and Selkoe, 2007), membrane-associated oligomerized A (Zhang et al.”
BackgroundMulti-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, E., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Wee Yong, V., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96
A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
Sun, L., Zhong, Y., Gui, J., Wang, X., Zhuang, X., & Weng, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152163 · Cited by 104
Miyashita, N., Straub, J. E., & Thirumalai, D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905457d · Cited by 106
Phospholipase D in brain function and Alzheimer's disease
Oliveira, T. G., & Di Paolo, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.004 · Cited by 97
“In the past few years it has been shown that soluble oligomeric Aβ40/42 in various assembly states better correlate with synaptic malfunction and cognitive impairment than neuritic plaques in vivo, consistent with mounting evidence that oligomeric Aβ is significantly synaptotoxic [1].”
BackgroundInfluentialDetection of Polyglutamine Protein Oligomers in Cells by Fluorescence Correlation Spectroscopy
Takahashi, Y., Okamoto, Y., Popiel, H. A., Fujikake, N., Toda, T., Kinjo, M., & Nagai, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704789200 · Cited by 105
Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release
Ferreira, I. L., Ferreiro, E. B., Schmidt, J., Cardoso, J. M. R., Pereira, C., Carvalho, A. L., Oliveira, C. R., & Rego, A. C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.006 · Cited by 111
Zempel, H., & Mandelkow, E.-M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0064-1 · Cited by 96
“AD-like pathological changes of Tau, we exposed primary neurons to a pre-aggregation form of Aβ (oligomeric Aβ), which is thought to be the toxic trigger in AD [3, 24, 35].”
Cell Adhesion, the Backbone of the Synapse: "Vertebrate" and "Invertebrate" Perspectives
Giagtzoglou, N., Ly, C. V., & Bellen, H. J. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003079 · Cited by 97
“Improper synapse formation and function may cause neurodevelopmental disorders, such as mental retardation (MsR) and autism spectrum disorders (ASD) (McAllister 2007; Sudhof 2008), and likely play a role in neurodegenerative disorders, such as Alzheimer's disease (AD) (Haass and Selkoe 2007).”
BackgroundPeripherally Applied Synthetic Peptide isoAsp7-Aβ(1-42) Triggers Cerebral β-Amyloidosis
Kozin, S. A., Cheglakov, I. B., Ovsepyan, A. A., Telegin, G. B., Tsvetkov, P. O., Лисица, А. В., & Makarov, A. А. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9399-y · Cited by 101
“…fluid, brain interstitial fluid), undergoes pathological conversion from its benign mostly monomeric state through soluble neurotoxic oligomers into insoluble dense-core (neuritic) amyloid plaques in specific areas of the brain (Gandy et al. 2010; Haass and Selkoe 2007; Holtzman et al. 2011).”
Whittington, R. A., Bretteville, A., Dickler, M. F., & Planel, E. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.03.004 · Cited by 96
Dutta, S., Foley, A. R., Warner, C. J. A., Zhang, X., Rolandi, M., Abrams, B., & Raskatov, J. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706279 · Cited by 96
Lee, B. I., Chung, Y. J., & Park, C. B. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.043 · Cited by 100
The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils
Thacker, D., Sanagavarapu, K., Frohm, B., Meisl, G., Knowles, T. P. J., & Linse, S. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002956117 · Cited by 100
Abramov, A. Y., Ionov, M., Pavlov, E., & Duchen, M. R. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00685.x · Cited by 96
“Senile plaques are formed extracellularly and consist of insoluble aggregates of different isoforms (39–42 amino acids) of amyloid b (bA) peptide (Masters et al., 1985; Haass & Selkoe, 2007).”
BackgroundZolezzi, J. M., Silva-Alvarez, C., Ordenes, D., Godoy, J. A., Carvajal, F. J., Santos, M. J., & Inestrosa, N. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064019 · Cited by 96
Boridy, S., Takahashi, H., Akiyoshi, K., & Maysinger, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.010 · Cited by 103
Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.-M., & Raussens, V. (2011) · The FASEB Journal · doi:10.1096/fj.10-175976 · Cited by 92
“(3), which assumes that soluble oligomers are the main”
BackgroundDislich, B., & Lichtenthaler, S. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00008 · Cited by 76
“The amyloid hypothesis states that the main constituent of amyloid plaques, the 39–43 amino acid long amyloid-β-peptide (Aβ), is responsible for the initiation of a neurotoxic cascade that ultimately leads to neuronal death and dementia (Hardy and Selkoe, 2002; Haass and Selkoe, 2007).”
BackgroundAβ Oligomers Induce Glutamate Release from Hippocampal Neurons
Brito-Moreira, J., C. Paula-Lima, A., R. Bomfim, T., F. Oliveira, F., J. Sepulveda, F., G. De Mello, F., G. Aguayo, L., Panizzutti, R., & T. Ferreira, S. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391917 · Cited by 96
The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
Wolfe, M. S. (2012) · Scientifica · doi:10.6064/2012/796024 · Cited by 96
Matsuda, S., Giliberto, L., Matsuda, Y., McGowan, E. M., & D'Adamio, L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2094-08.2008 · Cited by 95
“Although A 40 represents the majority product, A 42 is the main A species found in amyloid plaques because it is prone to oligomerization (Haass and Selkoe, 2007).”
BackgroundAFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Ruggeri, F. S., Habchi, J., Cerreta, A., & Dietler, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518141911 · Cited by 98
“Alzheimer’s disease (AD) is one of over 50 related amyloid disorders that are characterized by the misfolding of soluble proteins and their subsequent conversion into amyloid fibrils [4, 74, 75].”
BackgroundThe coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer’s disease
Boon, B. D. C., Bulk, M., Jonker, A. J., Morrema, T. H. J., van den Berg, E., Popovic, M., Walter, J., Kumar, S., van der Lee, S. J., Holstege, H., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02198-8 · Cited by 93
Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration
Penazzi, L., Bakota, L., & Brandt, R. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.09.004 · Cited by 110
Advances in Alzheimer’s Disease Drug Development
Rafii, M. S., & Aisen, P. S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0297-4 · Cited by 94
“APP is a single-pass membrane protein that is cleaved in the luminal/ extracellular region by beta-secretase and within the transmembrane domain by gamma-secretase to release A β [25].”
Brender, J., Krishnamoorthy, J., Sciacca, M. F. M., Vivekanandan, S., D’Urso, L., Chen, J., Rosa, C. L., & Ramamoorthy, A. (2015) · The Journal of Physical Chemistry B · doi:10.1021/jp511758w · Cited by 103
Fukumori, A., & Steiner, H. (2016) · The EMBO Journal · doi:10.15252/embj.201694151 · Cited by 94
“…preferentially oligomerize into toxic species that eventually form insoluble fibrils that are deposited in the brain of patients as senile plaques (Haass & Selkoe, 2007). c -Secretase is structurally the most complex intramembrane protease (Bai et al , 2015b) and the only known one, which…”
Graham, S. H., & Liu, H. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.011 · Cited by 94
“These toxins include abnormally folded or aggregated proteins (Haass and Selkoe, 2007).”
Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation
Stewart, K. L., & Radford, S. E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0271-9 · Cited by 102
“Oligomers of Aβ42 in particular (which may be transient or long-lived) have been implicated as cytotoxic disease-causative agents in AD (Haass and Selkoe 2007).”
BackgroundPavoni, S., Jarray, R., Nassor, F., Guyot, A.-C., Cottin, S., Rontard, J., Mikol, J., Mabondzo, A., Deslys, J.-P., & Yates, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209150 · Cited by 97
Mirza, F. J., Amber, S., Sumera, S., Hassan, D., Ahmed, T., & Zahid, S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153490 · Cited by 99
Garbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2021) · Molecular Biology · doi:10.1134/s002689332104004x · Cited by 103
Biophysical insight into the anti-amyloidogenic behavior of taurine
Chaturvedi, S. K., Alam, P., Khan, J. M., Siddiqui, M. K., Ponnusamy, K., Subbarao, N., Ahmad, Z., & Khan, R. H. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.06.035 · Cited by 94
Fan, H., Gu, R., Wang, Y., Pi, Y.-L., Zhang, Y., Xu, Q., & Wei, D. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b03116 · Cited by 98
Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria
Saraiva, L. M., Seixas da Silva, G. S., Galina, A., da-Silva, W. S., Klein, W. L., Ferreira, S. T., & De Felice, F. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015230 · Cited by 94
“Oligomers of the Ab peptide decrease mitochondrialbound HKI and impair neuronal energy metabolism Because soluble Ab oligomers (also known as ADDLs) have recently been recognized as the proximal neurotoxins in AD [17– 19], we next investigated whether a defined preparation of soluble Ab oligomers would instigate HKI r…”
BackgroundThe Dynamic Structure of Filamentous Tau
Bibow, S., Mukrasch, M. D., Chinnathambi, S., Biernat, J., Griesinger, C., Mandelkow, E., & Zweckstetter, M. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105493 · Cited by 94
Kabuta, T., Setsuie, R., Mitsui, T., Kinugawa, A., Sakurai, M., Aoki, S., Uchida, K., & Wada, K. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn037 · Cited by 100
Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability
Wang, X., L. Michaelis, M., & K. Michaelis, E. (2010) · Current Genomics · doi:10.2174/138920210793360943 · Cited by 93
“Region-specific dysfunction in synaptic transmission may result not only from the down-regulation of the genes described above, but also from direct effects of A on synaptic macromolecules [120, 121], or from the effects of products of chronic inflammatory response, such as tumor necrosis factor [122], or from other f…”
BackgroundBleiholder, C., Do, T., Wu, C., Economou, N. J., Bernstein, S. S., Buratto, S., Shea, J., & Bowers, M. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406197f · Cited by 88
Silva-Alvarez, C., Arrázola, M. S., Godoy, J. A., Ordenes, D., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00097 · Cited by 93
“Considering Aβ-mediated neurotoxicity in AD (Haass and Selkoe, 2007; Ballard et al., 2011), we evaluated the effect of Aβo and the participation of Sarco/Endoplasmic reticulum Ca+2-ATPases (SERCA) in this process.”
BackgroundNovel properties and applications of chiral inorganic nanostructures
Xiao, L., An, T., Wang, L., Xu, X., & Sun, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100824 · Cited by 95
Hammer, N. D., Wang, X., McGuffie, B. A., & Chapman, M. R. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13406 · Cited by 91
“Several lines of evidence link A β PP and misfolded A β to AD (for review see [13,45,50]).”
Fu, W., Ruangkittisakul, A., MacTavish, D., Shi, J. Y., Ballanyi, K., & Jhamandas, J. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331181 · Cited by 93
“Drug Treatment—Cell dysfunction and cell death resulting from exposure to A or hAmylin are mediated by soluble small or intermediate oligomers, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers (5, 22, 23).”
BackgroundNeurodegenerative diseases and exposure to the environmental metals Mn, Pb, and Hg
Charlet, L., Chapron, Y., Faller, P., Kirsch, R., Stone, A. T., & Baveye, P. C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.012 · Cited by 92
Jiang, J., & Jiang, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3424 · Cited by 97
Parthsarathy, V., McClean, P. L., Hölscher, C., Taylor, M., Tinker, C. L., Jones, G., Kolosov, O., Salvati, E., Gregori, M., Masserini, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054769 · Cited by 115
“Inhibition of toxic Ab oligomer formation is therefore a potential therapeutic target for AD and inhibitors of early-stage Ab aggregation could slow or even halt the progression of this disease [6-15].”
BackgroundAmyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1
Hernandez-Zimbron, L. F., Luna-Muñoz, J., Mena, R., Vazquez-Ramirez, R., Kubli-Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042344 · Cited by 92
“important role in the neuropathology of Alzheimer’s disease (AD) [1–8].”
BackgroundProteomic research in psychiatry
Taurines, R., Dudley, E., Grassl, J., Warnke, A., Gerlach, M., Coogan, A. N., & Thome, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106931 · Cited by 92
“Although the aetiopathology of AD dementia is currently incompletely ascertained, there is growing evidence that Abeta deposits and the reaction of the plaque surrounding tissue play major roles in disease development and progression (Haass and Selkoe, 2007; Montalto et al., 2007).”
BackgroundThe Biology of the Escherichia coli Extracellular Matrix
Hufnagel, D. A., DePas, W. H., & Chapman, M. R. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0014-2014 · Cited by 105
“Interestingly, acceleration of amyloid formation may be one route to prevent amyloid-related cellular toxicity, because conformationally dynamic amyloid intermediates are hypothesized to be the root of amyloid toxicity (124).”
BackgroundRosenman, D. J., Wang, C., & García, A. E. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b09379 · Cited by 98
A New Face for Old Antibiotics: Tetracyclines in Treatment of Amyloidoses
Stoilova, T., Colombo, L., Forloni, G., Tagliavini, F., & Salmona, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400161p · Cited by 93
Ionic Strength Modulation of the Free Energy Landscape of Aβ 40 Peptide Fibril Formation
Abelein, A., Jarvet, J., Barth, A., Gräslund, A., & Danielsson, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04511 · Cited by 97
Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing
Eckert, G. P., Chang, S., Eckmann, J., Copanaki, E., Hagl, S., Hener, U., Müller, W. E., & Kögel, D. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.10.014 · Cited by 92
Whiteman, I. T., Gervasio, O. L., Cullen, K. M., Guillemin, G. J., Jeong, E. V., Witting, P. K., Antao, S. T., Minamide, L. S., Bamburg, J. R., & Goldsbury, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3531-09.2009 · Cited by 92
“Alzheimer’s disease (AD) is a progressive, degenerative dementia histopathologically characterized by neurofibrillary tangles of tau protein and amyloid- (A ) plaques (Goedert and Spillantini, 2006; Haass and Selkoe, 2007).”
BackgroundDysregulated microRNAs in neurodegenerative disorders
Lau, P., & Strooper, B. D. (2010) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2010.01.009 · Cited by 101
Postu, P. A., Sadiki, F. Z., El Idrissi, M., Cioanca, O., Trifan, A., Hancianu, M., & Hritcu, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108673 · Cited by 92
Shih, Y.-H., Tu, L.-H., Chang, T.-Y., Ganesan, K., Chang, W.-W., Chang, P.-S., Fang, Y.-S., Lin, Y.-T., Jin, L.-W., & Chen, Y.-R. (2020) · Nature Communications · doi:10.1038/s41467-020-19786-7 · Cited by 91
Yeast as a model for studying human neurodegenerative disorders
Miller‐Fleming, L., Giorgini, F., & Outeiro, T. F. (2008) · Biotechnology Journal · doi:10.1002/biot.200700217 · Cited by 125
Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 101
dos Santos, V. V., Santos, D. B., Lach, G., Rodrigues, A. L. S., Farina, M., de Lima, T. C. M., & Prediger, R. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.039 · Cited by 98
Bouter, Y., Kacprowski, T., Weissmann, R., Dietrich, K., Borgers, H., Brauß, A., Sperling, C., Wirths, O., Albrecht, M., Jensen, L. R., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00075 · Cited by 76
“Frontiers in Aging Neuroscience www.frontiersin.org April 2014 | Volume 6 | Article 75 | 1 There is increasing evidence that AD is primarily initiated by soluble oligomeric species derived from full-length Aβ1–42 (Haass and Selkoe, 2007; Haupt et al., 2012).”
BackgroundInfluentialCrosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease
Santos, L. E., & Ferreira, S. T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.016 · Cited by 97
Long-Term Dabigatran Treatment Delays Alzheimer’s Disease Pathogenesis in the TgCRND8 Mouse Model
Cortes-Canteli, M., Kruyer, A., Fernandez-Nueda, I., Marcos-Diaz, A., Ceron, C., Richards, A. T., Jno-Charles, O. C., Rodriguez, I., Callejas, S., Norris, E. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.081 · Cited by 90
“Additionally, long-term anticoagulation decreased amyloid plaques, and, more importantly, halved levels of Ab oligomers (Figure 5), the toxic Ab species recognized as a main contributor to AD synaptic dysfunction (31).”
Chapter 5 Autophagic Clearance of Aggregate‐Prone Proteins Associated with Neurodegeneration
Sarkar, S., Ravikumar, B., & Rubinsztein, D. C. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(08)04005-6 · Cited by 79
Metadata
- Authors
- Haass, C., & Selkoe, D. J.
- Affiliations
- Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2007-02
- Volume
- 8
- Issue
- 2
- Pages
- 101-112
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1980825524
- Cited by
- 4,744
- References
- 135
- Citations by year
- 2026: 135 · 2025: 171 · 2024: 165 · 2023: 170 · 2022: 195 · 2021: 239 · 2020: 273 · 2019: 247 · 2018: 276 · 2017: 290 · 2016: 331 · 2015: 313 · 2014: 285 · 2013: 307 · 2012: 327
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, neurodegeneration, protein misfolding, protein aggregation, synaptic dysfunction, synaptic plasticity, Parkinson's disease, Huntington's disease, prion disease, neuronal dysfunction
- MeSH terms
- Alzheimer Disease, Cell Membrane, Humans, Memory Disorders, Models, Biological, Nerve Degeneration, Solubility, Synapses, Signal Transduction, Amyloid beta-Peptides, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.